Kruimelpad Home Development of TRNT radiopharmaceuticals targeting Hsp90 Development of TRNT radiopharmaceuticals targeting Hsp90 Universiteit KU LEUVEN Opleiding gestart op 01/10/2024 Mentor Vermeulen Koen Co-mentor Segers Charlotte Promotor Bormans Guy Kandidaat Van Winnendael Niels